Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe- Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors

Journal of Medicinal Chemistry

Volumn 40, Issue 11, 1997, Pages 1738-1748

  Haskell Luevano, Carrie ^a,e   Nikiforovich, Gregory ^c   Sharma, Shubh D ^d   Yang, Ying Kui ^a   Dickinson, Chris ^b   Hruby, Victor J ^d   Gantz, Ira ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d University of Arizona   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CYCLIC AMP; INTERMEDIN;

AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; ANALGESIA; ARTICLE; ATTENTION; BINDING AFFINITY; CALCULATION; COGNITION; DNA TEMPLATE; DRUG CONFORMATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; IMMUNOMODULATION; LEARNING; LIGAND BINDING; MELANOGENESIS; MEMORY; OBESITY; PROTEIN PROCESSING; RECEPTOR BINDING; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

EID: 0030950684     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960845e     Document Type: Article

References (69)

1. De Wied, D.; Jolles, J. Neuropeptides Derived from Pro-Opiocortin: Behavioral, Physiological, and Neurochemical Effects. Physiol. Rev. 1982, 62, 976-1059.
2. Hruby, V. J.; Wilkes, B. C.; Cody, W. L.; Sawyer, T. K.; Hadley, M. E. Melanotropins: Structural, Conformational and Biological Considerations in the Development of Superpotent and Superprolonged Analogs. Pept. Protein Rev. 1984, 3, 1-64.
3. Vaudry, H., Eberle, A. N., Eds. The Melanotropic Peptides. Ann. N. Y. Acad. Sci. 1993, 680, 1-687.
4. Lu, D.; Willard, D.; Patel, I. R.; Kadwell, S.; Overton, L.; Kost, T.; Luther, M.; Chen, W.; Yowchik, R. P.; Wilkison, W. O.; Cone, R. D. Agouti Protein is an Antagonist of the Melanocyte-Stimulating-Hormone Receptor. Nature 1994, 371, 799-802.
5. Fan, W.; Boston, B. A.; Kesterson, R. A.; Hruby, V. J.; Cone, R. D. Role of Melanocortinergic Neurons in Feeding and the agouti Obesity Syndrome. Nature 1997, 385, 165-168.
6. De Wied, D.; Croiset, G. Stress Modulation of Learning and Memory Processes. Methods Achieve Exp. Pathol. 1991, 15, 167-199.
7. Walker, J. M.; Akil, H.; Watson, S. J. Evidence for Homologous Actions of Pro-opiomelanocortin Products. Science 1980, 210, 1247-1249.
8. Smith, E. M.; Hughes, T. K.; Hashemi, F.; Stefano, G. B. Immunosuppressive Effects of Corticotropin and Melanotropin and Their Possible Significance in Human Immunodeficiency Virus Infection. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 782-786.
9. Dorr, R. T.; Lines, R.; Levine, N.; Brooks, C.; Xiang, L.; Hruby, V. J.; Hadley, M. E. Evaluation of Melanotan-II, a Superpotent Cyclic Melanotropic Peptide in a Pilot Phase-I Clinical Study. Life Sci. 1996, 58, 1777-1784.
10. Suzuki, I.; Cone, R. D.; Im, S.; Nordlund, J.; Abdel-Malek, Z. A. Binding of Melanotropic Hormones to the Melanocortin Receptor MC1R on Human Melanocytes Stimulates Proliferation and Melanogenesis. Endocrinology 1996, 137, 1627-1633.
11. Li, S.-J.; Varga, K.; Archer, P.; Hruby, V. J.; Sharma, S. D.; Kesterson, R. A.; Cone, R. D.; Kunos, G. Melanocrotin Antagonists Define Two Distinct Pathways of Cardiovascular Control by α- and γ-Melanocyte-Stimulating Hormones. J. Neurosci. 1996, 16, 5182-5188.
12. Hadley, M. E.; Sharma, S. D.; Hruby, V. J.; Levine, N.; Dorr, R. T. Melanotropic Peptides for Therapeutic and Cosmetic Tanning of the Skin. Ann. N. Y. Acad. Sci. 1993, 680, 424-439.
13. Mountjoy, K. G.; Robbins, L. S.; Mortrud, M. T.; Cone, R. D. The Cloning of a Family of Genes that Encode the Melanocortin Receptors. Science 1992, 257, 1248-1251.
14. Chhajlani, V.; Wikberg, J. E. S. Molecular Cloning and Expression of the Human Melanocyte Stimulating Hormone Receptor cDNA. FEBS Lett. 1992, 309, 417-420.
15. Chhajlani, V.; Muceniece, R.; Wikberg, J. E. S. Molecular Cloning of a Novel Human Melanocortin Receptor. Biochem. Biophys. Res. Commun. 1993, 195, 866-873.
16. Gantz, I.; Konda, Y.; Tashiro, T.; Shimoto, Y.; Miwa, H.; Munzert, G.; Watson, S. J.; DelValle, J.; Yamada, T. Molecular Cloning of a Novel Melanocortin Receptor. J. Biol. Chem. 1993, 268, 8246-8250.
17. Gantz, I.; Miwa, H.; Konda, Y.; Shimoto, Y.; Tashiro, T.; Watson, S. J.; DelValle, J.; Yamada, T. Molecular Cloning, Expression, and Gene Localization of a Fourth Melanocortin Receptor. J. Biol. Chem. 1993, 268, 15174-15179.
18. Miwa, H.; Gantz, I.; Konda, Y.; Shimoto, Y.; Yamada, T. Structural Determinants of the Melanocortin Peptides Required for Activation of Melanocortin-3 and Melanocortin-4 Receptors. J. Pharmacol. Exp. Ther. 1995, 273, 367-372.
19. Adan, R. A. H.; Oosterom, J.; Ludvigsdottir, G.; Brakkee, J. H.; Burbach, J. P. H.; Gispen, W. H. Identification of Antagonists for Melanocortin MC3, MC4 and MC5 receptors. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 1994, 269, 331-7.
20. Chhajlani, V. Characterization of a Putative α-MSH Antagonist 153N-6 at Melanocortin Receptor Subtypes by Radioligand Binding. Peptides 1996, 17, 349-351.
21. 2 With Bulky Aromatic Amino Acids at Position 7 Show High Antagonist Potency and Selectivity at Specific Melanocortin Receptors. J. Med. Chem. 1995, 38, 3454-3461.
22. Haskell-Luevano, C.; Boteju, L. W.; Miwa, H.; Dickinson, C.; Gantz, I.; Yamada, T.; Hadley, M. E.; Hruby, V. J. Topographical Modifications of Melanotropin Peptide Analogues with β-Methyltryptophan Isomers at Position 9 Leads to Differential Potencies and Prolonged Biological Activities. J. Med. Chem. 1995, 38, 4720-4729.
23. Hruby, V. J.; Wilkes, B. C.; Hadley, M. E.; Al-Obeidi, F.; Sawyer, T. K.; Staples, D. J.; DeVaux, A.; Dym, O.; Castrucci, A. M.; Hintz, M. F.; Riehm, J. P.; Rao, K. R. α-Melanotropin: The Minimal Active Sequence in the Frog Skin Bioassay. J. Med. Chem. 1987, 30, 2126-2130.
24. Castrucci, A. M. L.; Hadley, M. E.; Sawyer, T. K.; Wilkes, B. C.; Al-Obeidi, F.; Staples, D. J.; DeVaux, A. E.; Dym, O.; Hintz, M. F.; Riehm, J.; Rao, K. R.; Hruby, V. J. α-Melanotropin: The Minimal Active Sequence in the Lizard Skin Bioassay. Gen. Comp. Endocrinol. 1989, 73, 157-163.
25. 7] α-MSH: Discovery of a Tripeptidyl Agonist Exhibiting Sustained Bioactivity. Ann. N. Y. Acad. Sci. 1993, 680, 597-599.
26. Haskell-Luevano, C.; Sawyer, T. K.; Hendrata, S.; North, C.; Panahinia, L.; Stum, M.; Staples, D. J.; Castrucci, A. M.; Hadley, M. E.; Hruby, V. J. Truncation Studies of α-Melanotropin Peptides Identifies Tripeptide Analogues Exhibiting Prolonged Agonist Bioactivity. Peptides 1996, 17, 995-1002.
27. Hruby, V. J.; Al-Obeidi, F.; Kazmierski, W. Emerging Approaches In The Molecular Design of Receptor-Selective Peptide Ligands - Conformational, Topographical And Dynamic Considerations. Biochem. J. 1990, 268, 249-262.
28. Goodman, M.; Ro, S. Peptidomimetics for Drug Design. In Burger's Medicinal Chemistry and Drug Discovery; Wolff, M. E., Ed.; Wiley: New York, 1995; Vol. 1: Principles and Practice; pp 803-861.
29. 10]-α-Melanocyte-Stimulating Hormone: A Cyclic α-Melanotropin Exhibiting Superagonist Biological Activity. Proc. Natl. Acad. Sci. U.S.A. 1982, 79, 1751-1755.
30. Cody, W. L.; Mahoney, M.; Knittel, J. J.; Hruby, V. J.; Castrucci, A. M. L.; Hadley, M. E. Cyclic Melanotropins. 9. 7-D-Phenylalanine Analogues of the Active-Site Sequence. J. Med. Chem. 1985, 28, 583-588.
31. 2. Biochemistry 1988, 27, 8181-8188.
32. Al-Obeidi, F.; Hadley, M. E.; Pettitt, B. M.; Hruby, V. J. Design of a New Class of Superpotent Cyclic α-Melanotropins Based on Quenched Dynamic Stimulations. J. Am. Chem. Soc. 1989, 111, 3413-3416.
33. Al-Obeidi, F.; Castrucci, A. M.; Hadley, M. E.; Hruby, V. J. Potent and Prolonged Acting Cyclic Lactam Analogues of α-Melanotropin: Design Based on Molecular Dynamics. J. Med. Chem. 1989, 32, 2555-2561.
34. Nikiforovich, G. V.; Sharma, S. D.; Hadley, M. E.; Hruby, V. J. Design of Different Conformational Isomers of the Same Peptide: α-Melanotropin. In Peptides: Chemistry and Biology; Smith, J. A., Rivier, J. E., Eds.; ESCOM: Leiden, 1992; pp 389-392.
35. Bodi, J.; Medzihradszky-Schweiger, H.; Süli-Vargha, H. Synthesis and Biological Activity of Cyclic Melanotropin Peptides. In Peptides; Andreu, G. E., Andreu, D., Eds.; ESCOM Science: Leiden, 1991; pp 690-691.
36. Haskell-Luevano, C.; Shenderovich, M. D.; Sharma, S. D.; Nikiforovich, G. V.; Hadley, M. E.; Hruby, V. J. Design, Synthesis, Biology and Conformations of Bicyclic α-Melanotropin Peptide Analogues. J. Med. Chem. 1995, 38, 1736-1750.
37. Nikiforovich, G. V.; Sharma, S. D.; Hadley, M. E.; Hruby, V. J. Studies of Conformational Isomerism in α-MSH by Design of Cyclic Analogs. Biopolymers, submitted.
38. Sawyer, T. K.; Sanfillippo, P. J.; Hruby, V. J.; Engel, M. H.; Heward, C. B.; Burnett, J. B.; Hadley, M. E. 4-Norleucine, 7-D-Phenylalanine-α-Melanocyte-Stimulating Hormone: A Highly Potent α-Melanotropin with Ultra Long Biological Activity. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 5754-5758.
39. Hadley, M. E.; Anderson, B.; Heward, C. B.; Sawyer, T. K.; Hruby, V. J. Calcium-Dependent Prolonged Effects on Melanophores of [4-Norleucine, 7-D-Phenylalanine]-α-Melanotropin. Science 1981, 213, 1025-1027.
40. Haskell-Luevano, C.; Miwa, H.; Dickinson, C.; Hadley, M. E.; Hruby, V. J.; Yamada, T.; Gantz, I. Characterizations of the Unusual Dissociation Properties of Melanotropin Peptides From the Melanocortin Receptor, hMC1R. J. Med. Chem. 1996, 39, 432-435.
41. Nikiforovich, G. V.; Rozenbilt, S. A.; Shenderovich, M. D.; Chipens, G. I. Possible Bioactive Conformation of α-Melanotropin. FEBS 1984, 170, 315-320.
42. Low, M. J.; Simerly, R. B.; Cone, R. D. Receptors for the Melanocortin Peptides in the Central Nervous System. Curr. Opin. Endocrinol. Diabetes 1994, 1, 1068-3097.
43. Haskell-Luevano, C.; Sawyer, T. K.; Trumpp-Kallmeyer, S.; Bikker, J.; Humblet, C.; Gantz, I.; Hruby, V. J. Three-Dimensional Molecular Models of the hMC1R Melanocortin Receptor: Complexes with Melanotropin Peptide Agonists. Drug Des. Discovery 1996, 14, 197-211.
44. Roselli-Rehfuss, L.; Mountjoy, K. G.; Robbins, L. S.; Mortrud, M. T.; Low, M. J.; Tatro, J. B.; Entwistle, M. L.; Simerly, R. B.; Cone, R. D. Identification of a Receptor for γ Melanotropin and Other Proopiomelanocortin Peptides in the Hypothalamus and Limbic System. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 8856-8860.
45. Gantz, I.; Shimoto, Y.; Konda, Y.; Miwa, H.; Dickinson, C. J.; Yamada, T. Molecular Cloning, Expression, and Characterization of a Fifth Melanocortin Receptor. Biochem. Biophys. Res. Commun. 1994, 200, 1214-1220.
46. Chhajlani, V. Distribution of cDNA for Melanocortin Receptor Subtypes in Human Tissues. Biochem. Mol. Biol., in press.
47. Mountjoy, K. G.; Mortrud, M. T.; Low, M. J.; Simerly, R. B.; Cone, R. D. Localization of the Melanocortin-4 Receptor (MC4-R) in Neuroendocrine and Autonomic Control Circuits in the Brain. Mol. Endocrinol. 1994, 8, 1298-1308.
48. Haskell-Luevano, C.; Sawyer, T. K.; Hruby, V. J. Molecular Model of the G-Protein Coupled Melanocortin Receptor, hMC1R, and Proposed Interactions with α-MSH Peptides. In Peptides, Chemistry, Structure and Biology; Kaumaya, P. T. P., Hodges, R. S., Eds.; Mayflower Scientific Ltd: Kingswinford, England, 1996; pp 378-379.
49. Vanetti, M.; Schonrock, C.; Meyerhof, W.; Hollt, V. Molecular Cloning of a Bovine MSH Receptor Which is Highly Expressed in the Testis. FEBS Lett. 1994, 348, 268-272.
50. Våge, D. I.; D., L.; Klungland, H.; Lien, S.; Adalsteinsson, S.; Cone, R. D. A Non-epistatic Interaction of agouti and extension in the Fox, Vulpes Vulpes. Nature Gen. 1997, 15, 311-315.
51. Takeuchi, S.; Suzuki, S.; Hirose, S.; Yabuuchi, M.; Sato, C.; Yamamoto, H.; Takahashi, S. Molecular Cloning and Sequence Analysis of the Chick Melanocortin 1-Receptor Gene. Biochem. Biophys. Acta 1996, 1306, 122-126.
52. Mountjoy, K. G. The Human Melanocyte Stinulating Hormone Receptor has Evolved to Become "Super-Sensitive" to Melanocortin Peptides. Mol. Cell. Endocrinol. 1994, 102, R7-R11.
53. 7]-α-MSH at the Melanocortin-1 Receptor. Biochem. Biophys. Res. Commun. 1994, 202, 1266-1271.
54. Chini, B.; Mouillac, B.; Ala, Y.; Balestre, M.-N.; Trumpp-Kallmeyer, S.; Hoflack, J.; Elands, J.; Hibert, M.; Manning, M.; Jard, S.; Barberis, C. Tyr115 is the Key Residue for Determining Agonist Selectivity in the Via Vasopressin Receptor. EMBO J. 1995, 14, 2176-2182.
55. Kaupmann, K.; Bruns, C.; Raulf, F.; Weber, H. P.; Mattes, H.; Lübbert, H. Two Amino Acids, Located in Transmembrane Domains VI and VII, Determine the Selectivity of the Peptide Agonist SMS 201-995 for the SSTR2 Somatostatin Receptor. EMBO J. 1995, 14, 727-735.
56. Mouillac, B.; Chini, B.; Balestre, M.-N.; Elands, J.; Trumpp-Kallmeyer, S.; Hoflack, J.; Hibert, M.; Jard, S.; Barberis, C. The Binding Site of Neuropeptide Vasopressin VIa Receptor: Evidence for a Major Localization Within Transmembrane Regions. J. Biol. Chem. 1995, 270, 25771-15777.
57. Bond, R. A.; Leff, P.; Johnson, T. D.; Milano, C. A.; Rockman, H. A.; McMinn, T. R.; Apparsundaram, S.; Hyek, M. F.; Kenakin, T. P.; Allen, L. F.; Lefkowitz, R. J. Physiological Effects of Inverse Agonists in Transgenic Mice With Myocardial Over-expression of the β2-Adrenoceptor. Nature 1995, 374, 272-276.
58. Schwartz, T. W.; Gether, U.; Schambye, H. T.; Hjorth, S. A. Molecular Mechanism of Action of Non-peptide Ligands for Peptide Receptors. Curr. Pharm. Des. 1995, 1, 325-342.
59. Leff, P. The Two-State Model of Receptor Activation. Trends Pharmacol. Sci. 1995, 16, 89-97.
60. Kenakin, T. Receptor Conformation Induction Versus Selection: All Part of the Same Energy Landscape. Trends. Pharmacol. Sci. 1996, 17, 190-191.
61. Nikiforovich, G. V. Computational Molecular Modeling in Peptide Design. Int. J. Pept. Protein Res. 1994, 44, 513-531.
62. Hruby, V. J.; Sharma, S. D.; Toth, K.; Jaw, J. Y.; Al-Obeidi, F.; Sawyer, T. K.; de Lauro Castrucci, A. M. Design, Synthesis and Conformation of Superpotent and Prolonged Acting Melanotropins. Ann. N. Y. Acad. Sci. 1993, 680, 51-63.
63. Eberle, A. N. The Melanotropins: Chemistry, Physiology and Mechanisms of Action; Karger: Basel, 1988.
64. Tatro, J. B.; Reichlin, S. Specific Receptors for α-Melanocyte-Stimulating Hormone are Widely Distributed in Tissues of Rodents. Endocrinology 1987, 121, 1900-1907.
65. Bowen, W. P.; Jerman, J. C. Nonlinear Regression Using Spreadsheets. Trends Pharmacol. Sci. 1995, 16, 413-417.
66. Dunfield, L. G.; Burgess, A. W.; Scheraga, H. A. Energy Parameters in Polypeptides. 8. Empirical Potential Energy Algorithm for the Conformational Analysis of Large Molecules. J. Phys. Chem. 1978, 82, 2609-2616.
67. Némethy, G.; Pottle, M. S.; Scheraga, H. A. Energy Parameters in Polypeptides. 9. Updating of Geometrical Parameters, Non-bonded Interactions, and Hydrogen Bond Interactions for the Naturally Occurring Amino Acids. J. Phys. Chem. 1983, 87, 1883-1887.
68. Nikiforovich, G. V.; Hruby, V. J.; Prakash, O.; Gehrig, C. A. Topographical Requirements for Delta-Selective Opioid Peptides. Biopolymers 1991, 31, 941-955.
69. Baldwin, J. M. The Probable Arrangement of the Helices in G Protein-Coupled Receptors. EMBO J. 1993, 12, 1693-1703.